Paul DeJong will undergo season-ending hamstring surgery, the Triple-A Toledo Mud Hens and reporting make clear, ending his comeback bid less than three weeks after he last played. Jon Heyman reported at 6:51pm CDT on May 21, 2026: "Paul DeJong is having season-ending hamstring surgery."
The Mud Hens placed DeJong on their full-season injured list the same day, a move that converts what began as a short-term experiment into a definitive end to his 2026 campaign. DeJong had made just his sixth appearance for Toledo when the hamstring problem sidelined him; his last game was May 12, 2026, when he was visibly limping around the bases to score a run.
The numbers underline why this matters. DeJong has appeared in 925 career MLB games and was an All-Star in 2019 with the St. Louis Cardinals, credentials that made him an obvious reclamation target after a difficult 2025. He had hit six home runs in 83 plate appearances for the Yankees' Triple-A club earlier this season, and in 23 games in the Yankees system he hit.203 with 6 home runs and 13 RBIs before opting out of his minor league deal on May 1, 2026.
After leaving the Yankees' system, DeJong signed a minor league deal with the Tigers and was added to Toledo as infield depth while the big-league club battled its own injury list. The Tigers had Gleyber Torres, Trey Sweeney and Javier Báez on the injured list when they brought DeJong in, a sign the organization viewed him as a near-term option if he stayed healthy.
Scouts and beat writers had mixed reads on whether DeJong had re-established himself. The Athletic’s Brendan Kuty wrote that DeJong "looked really good" during his brief time after signing with Detroit, a praise that cut against the cold arithmetic of his season totals and recent durability concerns. Those totals—a.203 average with modest counting stats in a small sample—suggested he had not yet done enough to force a major-league recall.
The backstory makes the setback sharper. DeJong missed more than two months last year after a fastball struck his face and caused several fractures; that injury-marred season fed the urgency of his short-term tours through two organizations this spring. The hamstring operation ends DeJong's chance to use the rest of 2026 to rebuild value or push for a return to a big-league roster.
The immediate tension is practical: a veteran with a long track record is now without an opportunity to add to it for the rest of the year, and a Tigers depth chart that briefly expanded with his signing has contracted again. For DeJong, who has 1,327 plate appearances since 2019 that include 30 home runs and 78 RBIs in a recent window of 57 games and 50 homers in another referenced stretch, the missed time is not merely a lost season but a lost audition.
This is also a personnel problem for Detroit. The Tigers turned to DeJong precisely because they were carrying multiple infield injuries. With DeJong sidelined, the club will have to plug that gap with other internal options or another signing—choices that will matter for how the roster handles the remainder of the American League calendar.
DeJong’s surgery makes one fact unavoidable: his 2026 season is over. That is the clear, unsentimental conclusion the facts support. The next consequential question for DeJong is how the operation and his recovery will affect his market next winter; for the Tigers, it is how quickly they can replace the depth they had hoped he would supply.
